What's next for the weight-loss drug maker?
Shares in Danish biotech Zealand Pharma plunged recently after detailed data on its weight-loss drug survodutide showed much higher patient…
Biotechnology and pharmaceuticals
Huntington's disease drug maker UniQure to seek FDA approval for gene therapy
Thomas Fuller | SOPA Images | Light rocket | fake images UniQure plans to seek FDA approval for its experimental…
Biotech IPO window is open, but big pharma M&As set the pace: bankers
Public markets are beginning to reopen for biotech companies after several years of subdued activity. But stronger companies are still…
Lilly, Novo and Pfizer seek new weight loss drugs
Drug makers have only been introducing GLP-1 pills for a few months and are undergoing big changes to the way…
CVS Health Executives on Reducing Healthcare's Biggest Pain Points
Nikolas Kokovlis | Nurfoto | fake images A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing…
Novo Nordisk and Eli Lilly launch anti-obesity pills and prepare for Medicare coverage
Nordisk and Eli Lilly They took their battle against the GLP-1 pill to the biggest meeting on obesity this weekend…
Shares of weight-loss drug makers plunge 25% as safety data spooks investors
Shares in weight-loss drug maker Zealand Pharma plunged as much as 26% on Monday after new data on its experimental…
Abivax Shares Plunge Amid Cancer Cases in Bowel Disease Drug Trial
Actions of Abivax It closed down 43.6% on Tuesday after reporting new data on its top asset, an ulcerative colitis…
Summit Akeso ivonescimab improves survival in Harmoni-6 trial
Piotr Swat | Light rocket | fake images An experimental drug against lung cancer from Akeso and Summit Therapeutics reduced…
Replimune to reintroduce melanoma drug after Makary leaves FDA
Thomas Fuller | Light rocket | fake images Replimune plans to resubmit its melanoma drug to the Food and Drug…